Empower Clinics (CSE: CBDT – OTCQB: EPWCF) CEO Steven McAuley joined Steve Darling from Proactive to bring news the company has added to their testing business with the acquisition of MediSure Canada which is a leading Canadian manufacturer of medical devices for patients managing diabetes.
McAuley telling Proactive this now bolsters their direct-to-consumer testing products initiative, while expanding Empower’s overall service offerings on an accelerated basis. That company, MediSure, is a leader in the consumer-driven healthcare sector with a presence in over 4,000 Canadian pharmacies, 50,000 end-users and unaudited twelve-month trailing revenues of 1.9 million.